News
For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...
Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
StockStory.org on MSN16h
Hims & Hers Health’s Q1 Earnings Call: Our Top 5 Analyst QuestionsHims & Hers Health delivered a first quarter that surpassed Wall Street’s expectations, driven by strong adoption of its ...
For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and MIDAS scores.
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
Due to popularity of the medications, GLP-1s were in short supply up until recently. Obesity is a common issue among ...
Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...
Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...
A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results